<DOC>
	<DOCNO>NCT01364779</DOCNO>
	<brief_summary>The primary objective study determine prevalence aspirin resistance chronic kidney disease patient . The secondary objective determine possible risk factor contribute aspirin resistance population .</brief_summary>
	<brief_title>Prevalence Aspirin Resistance Chronic Kidney Disease Patients</brief_title>
	<detailed_description>A cross-sectional `` aspirin resistance hemodialysis patient '' previously do institution show 23/66 ( 34.7 % ) hemodialysis patient aspirin resistant . In recent systematic review , renal impairment associate aspirin resistance . This association see two twenty study use meta-analysis . Both study center predominant Asian population . In study try evaluate prevalence aspirin resistance CKD patient without limited specific ethnicity .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients know structural kidney disease evident history urinalysis CKD stage III IV determine MDRD formula take aspirin . Younger 18 year age . Bleeding disorder myeloproliferative disorder . Thrombocytopenia platelets &lt; 100.000 . Malignancy . Acute hemorrhagic disease . A recent history receipt platelet glycoprotein IIb/IIIa blocker . Liver disease evident abnormal liver function total bilirubin &gt; 2mg/dl . use anticoagulation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>aspirin</keyword>
	<keyword>Chronic kidney disease</keyword>
</DOC>